These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8053980)
21. Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Boccuzzi G; Aragno M; Brignardello E; Tamagno E; Conti G; Di Monaco M; Racca S; Danni O; Di Carlo F Anticancer Res; 1992; 12(5):1479-83. PubMed ID: 1444210 [TBL] [Abstract][Full Text] [Related]
22. Enhanced cytostatic effectiveness of aniline mustard against 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors during regression in response to ovariectomy. Benckhuysen C; Ter Hart HG; Van Dijk PJ Cancer Treat Rep; 1981; 65(7-8):567-74. PubMed ID: 6788369 [TBL] [Abstract][Full Text] [Related]
23. Adrenal regulation of mammary tumorigenesis in female Sprague-Dawley rats: incidence, latency, and yield of mammary tumors. Carter JH; Carter HW; Meade J Cancer Res; 1988 Jul; 48(13):3801-7. PubMed ID: 3132320 [TBL] [Abstract][Full Text] [Related]
24. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats. Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706 [TBL] [Abstract][Full Text] [Related]
25. Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor. Bhatnagar AS; Häusler A; Schieweck K; Lang M; Bowman R J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1021-7. PubMed ID: 2149502 [TBL] [Abstract][Full Text] [Related]
26. [Introduction of a new aromatase inhibitor fadrozole hydrochloride hydsate]. Tsukagoshi S Gan To Kagaku Ryoho; 1995 Nov; 22(13):1991-7. PubMed ID: 7487133 [TBL] [Abstract][Full Text] [Related]
27. Coadministration of the aromatase inhibitor formestane and an isopropanolic extract of black cohosh in a rat model of chemically induced mammary carcinoma. Nisslein T; Freudenstein J Planta Med; 2007 Apr; 73(4):318-22. PubMed ID: 17354167 [TBL] [Abstract][Full Text] [Related]
28. Change in chemosensitivity of DMBA-induced rat mammary tumor after oophorectomy. Isogai M; Kondo K; Kitamura N Anticancer Res; 1998; 18(2A):963-6. PubMed ID: 9615747 [TBL] [Abstract][Full Text] [Related]
30. Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors. Schieweck K; Bhatnagar AS; Batzl C; Lang M J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):633-6. PubMed ID: 8476774 [TBL] [Abstract][Full Text] [Related]
31. Effects of sequential and combined endocrine therapies on the growth of 7,12-dimethylbenz [alpha] anthracene-induced rat mammary carcinoma. Iino Y; Ogawa T; Yoshida M; Ishikawa H; Izuo M; Takikawa H Jpn J Clin Oncol; 1990 Sep; 20(3):259-62. PubMed ID: 2147726 [TBL] [Abstract][Full Text] [Related]
32. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinomas. Weckbecker G; Tolcsvai L; Stolz B; Pollak M; Bruns C Cancer Res; 1994 Dec; 54(24):6334-7. PubMed ID: 7987824 [TBL] [Abstract][Full Text] [Related]
33. Obesity increases the incidence of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in an ovariectomized Zucker rat model. Hakkak R; MacLeod S; Shaaf S; Holley AW; Simpson P; Fuchs G; Jo CH; Kieber-Emmons T; Korourian S Int J Oncol; 2007 Mar; 30(3):557-63. PubMed ID: 17273756 [TBL] [Abstract][Full Text] [Related]
34. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats. Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869 [TBL] [Abstract][Full Text] [Related]
35. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis. Abou-Issa HM; Alshafie GA; Seibert K; Koki AT; Masferrer JL; Harris RE Anticancer Res; 2001; 21(5):3425-32. PubMed ID: 11848504 [TBL] [Abstract][Full Text] [Related]
36. Effects of combined and sequential treatment with tamoxifen and the aromatase inhibitor vorozole on 7,12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat. Van Ginckel R; Janssens B; Callens M; Goeminne N; Wouters L; De Coster R Cancer Chemother Pharmacol; 1996; 38(1):21-8. PubMed ID: 8603447 [TBL] [Abstract][Full Text] [Related]
37. Combined effects of lutenizing hormone-releasing hormone analogue with antiestrogen on rat mammary tumors. Matsumoto H; Koibuchi Y; Horiguchi J; Iino Y; Morishita Y Oncol Rep; 2002; 9(1):145-51. PubMed ID: 11748473 [TBL] [Abstract][Full Text] [Related]
38. Modification of the effect of a gonadoliberin analog on 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by hormone replacement. Rose DP; Pruitt B Cancer Res; 1979 Oct; 39(10):3968-70. PubMed ID: 113083 [TBL] [Abstract][Full Text] [Related]
39. Effect of aromatase inhibitors on estrogen 2-hydroxylase in rat liver. Purba HS; King EJ; Richert P; Bhatnagar AS J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):215-9. PubMed ID: 8142297 [TBL] [Abstract][Full Text] [Related]
40. The new aromatase inhibitor CGS-16949A suppresses aldosterone and cortisol production by human adrenal cells in vitro. Lamberts SW; Bruining HA; Marzouk H; Zuiderwijk J; Uitterlinden P; Blijd JJ; Hackeng WH; De Jong FH J Clin Endocrinol Metab; 1989 Oct; 69(4):896-901. PubMed ID: 2550511 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]